Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tabernero

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Molecular biology of testicular germ cell tumorsE Vilar, E Calvo, J Tabernero
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Biomarkers in colorectal cancerB Markman, V Rodríguez-Freixinos, J Tabernero
The Lancet. Oncology|June 13, 2015
Correction to Lancet Oncol 2015; 16: 499-508. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 studyJ Tabernero, Y Takayuki, A L Cohn
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1997
[Myo-pericarditis caused by Toxoplasma gondii]M Alvarez, F Gutiérrez, A Benito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2023
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancerJ Ros, A Vivancos, J Tabernero, et al.
Addiction Biology|June 26, 2010
Analysis of opiates and cocaine by RIA and GC-MS: distribution of their metabolites in urine and hair from drug addictsM J Tabernero, A M Bermejo, P Fernandez
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2021
Building bridges between drug development and cancer science: a tribute to José Baselga's legacyD M Hyman, J-C Soria, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et alS Banerjee, M Preusser, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2020
Clinical development of therapies targeting TGFβ: current knowledge and future perspectivesD Ciardiello, E Elez, J Tabernero, et al.
Journal of Analytical Toxicology|February 2, 2000
Saliva/plasma ratio of methadone and EDDPA M Bermejo, A C Lucas, M J Tabernero
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Molecular biology of testicular germ cell tumorsE Vilar, E Calvo, J Tabernero
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Biomarkers in colorectal cancerB Markman, V Rodríguez-Freixinos, J Tabernero
The Lancet. Oncology|June 13, 2015
Correction to Lancet Oncol 2015; 16: 499-508. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 studyJ Tabernero, Y Takayuki, A L Cohn
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1997
[Myo-pericarditis caused by Toxoplasma gondii]M Alvarez, F Gutiérrez, A Benito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2023
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancerJ Ros, A Vivancos, J Tabernero, et al.
Addiction Biology|June 26, 2010
Analysis of opiates and cocaine by RIA and GC-MS: distribution of their metabolites in urine and hair from drug addictsM J Tabernero, A M Bermejo, P Fernandez
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2021
Building bridges between drug development and cancer science: a tribute to José Baselga's legacyD M Hyman, J-C Soria, J Tabernero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et alS Banerjee, M Preusser, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2020
Clinical development of therapies targeting TGFβ: current knowledge and future perspectivesD Ciardiello, E Elez, J Tabernero, et al.
Journal of Analytical Toxicology|February 2, 2000
Saliva/plasma ratio of methadone and EDDPA M Bermejo, A C Lucas, M J Tabernero
Pageof 21